You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
Dermatology
Diving Below the Surface of AD: The Role of Type 2 Inflammation
This video from the September 2024 ADVENT symposium at EADV’s Annual Meeting in Amsterdam, the Netherlands, features Dr. Stephan Weidinger discussing how local type 2 inflammation at the skin tissue level contributes to epidermal barrier dysfunction, dysbiosis, and neuroimmune dysfunction, leading to the clinical signs and symptoms of AD. Dr. Weidinger also reviews how systemic inflammation affects organ systems beyond the skin and can manifest as atopic and non-atopic comorbidities.
MD, PhD
Stephan Weidinger
Learning objectives
- • Explore the ways in which type 2 inflammation, including IL-4 and IL-13, contributes to AD disease pathogenesis within the skin
- • Discuss how systemic inflammation may affect organ systems beyond the skin
Tags
MAT-GLB-2406718 - 3.0 - 02/2025
About this expert
Dermatology
Stephan Weidinger
MD, PhD
Professor and Chair for Dermatology at the Christian-Albrechts-University; Director of the Department of Dermatology and Allergy at the University Hospital Schleswig-Holstein, Campus Kiel, Germany
See author’s profileRelated resources
